Determination of Regulatory Review Period for Purposes of Patent Extension; Therma Choice Uterine Ballon Therapy System.
(28MAY99) Click here for txt or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Omnicef Tablets. (21MAY99) Click here for txt or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Tazorac. (21MAY99) Click here for txt or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Omnicef Oral Suspension. (20MAY99) Click here for
txt
or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Neumega. (19MAY99) Click here for txt or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Trovan. (19MAY99) Click here for txt or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Monostrut Cardiac Valve Prosthesis. (19MAY99) Click
here for txt
or
pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Lotemax and Alrex (18MAY99) Click here for txt or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Aggrastat. (11MAY99) Click here for txt or pdf |
Docket No. 98E-0319, OC99115. Determination of Regulatory Review Period for Purposes of Patent Extension; GenESA. (11MAY99)
Click here for
txt or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Femara. (10MAY99) Click here for txt or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Gonal. [TXT] [PDF] (30 APR99)
Click here for
txt
or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Amerge. [TXT] [PDF] (29APR99)
Click here for
txt
or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Regranex and Becaplermin Concentrate. (04MAR99)
Click here for txt or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; LumenHance. (03MAR99)
Click here for txt
or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Singulair. (03MAR99)
Click here for txt
or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Atacand. Page 10156 [FR Doc. 99-5032]
(02MAR99)
Click here for txt or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Zemplar. (01MAR99)
Click here for txt
or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Prandin (5,216,167). (28JAN99)
Click here for txt
or pdf |
Docket No. 98E-0475, OC9920. Determination of Regulatory Review Period for Purposes of Patent Extension; Prandin (5,312,9240).
(28JAN99)
Click here for txt or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Emadine. (27JAN99)
Click here for txt
or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Viagra. (27JAN99)
Click here for txt
or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Xeloda. (27JAN99)
Click here for txt
or pdf |
Determination of Regulatory Review Period for Purposes of Patent Extension; Anzemet. (26JAN99)
Click here for txt
or pdf |
